NonprofitsCancer Research & Treatment Fund Inc

Cancer Research & Treatment Fund Inc

NEW YORK, NY

Total revenue

$1.1M

Total expenses

$1.0M

Net assets

$14.9M

Grants received

$601K

56 grants

EIN

136272085

Tax year

2024

Mission

To provide resources for state of the art research that leads to effective treatment of cancers.

Financials

FY 2024

Revenue

Contributions & grants$776K
Program service revenue
Investment income$511K
Other revenue
Total revenue$1.1M

Expenses

Grants paid$543K
Salaries & benefits$293K
Fundraising$150K
Other expenses$169K
Total expenses$1.0M
Total assets$15.2M
Net assets$14.9M

People

18 listed

NameRoleCompensation

RICHARD TSILVER MD

Director

Board

$120K

40 hrs/wk

DAVID BOULE

Director

Board

3 hrs/wk

RICHARD ROSE

Director

Board

1 hrs/wk

TODD SHAW

Director

Board

1 hrs/wk

ADAM SILVER

Director

Board

1 hrs/wk

CALEB SEXTON

Director

Board

1 hrs/wk

JEFFREY PUGLISIMD

Director

Board

0

AMANDA JOHNS PEREZ

Director

Board

1 hrs/wk

RAJESH SHAH

Director

Board

1 hrs/wk

TERRY HERMANSON

Director

Board

1 hrs/wk

MICHAEL C KEMPNER

Director

Board

1 hrs/wk

MARIA BRISBANE

Director

Board

1 hrs/wk

KASIA McCORMICK

Director

Board

1 hrs/wk

NELSON BOXER

Director

Board

1 hrs/wk

TIM SILVER

Director

Board

1 hrs/wk

AJ SHIEKMAN

Director

Board

1 hrs/wk

THOMAS SILVER

Director

Board

3 hrs/wk

ANNE TEMPLETON

Director

Board

1 hrs/wk

Grants received

Showing 56 of 56

FromAmountPurposeYear
$30K
UNRESTRICTED GENERAL SUPPORT
2024
$10K
GENERAL SUPPORT
2024
$10K
UNRESTRICTED GRANT TO FURTHER THE ORGANIZATION'S EXEMPT PURPOSE.
2024
$10K
13th International Patient Symposium on Myeloproliferative Neoplasms Fund
2024
$360
GENERAL OPERATING SUPPORT
2024
$50
VOLUNTEER PROGRAM
2024
$25K
UNRESTRICTED GENERAL SUPPORT
2023
$17K
FOR RECIPIENT'S EXEMPT PURPOSE
2023
$15K
IN FURTHERANCE OF GRANTEE'S TAX-EXEMPT PURPOSE
2023
$10K
MEDICAL / PUBLIC SERVICES
2023
$8K
FUNDING RESEARCH GRANTS IN CANCER RESEARCH
2023
$5K
General & Unrestricted
2023
$5K
12th International Patient Symposium on Myeloproliferative Neoplasms (MPNs)
2023
$4K
PUBLIC CHARITY
2023
$1K
GENERAL SUPPORT
2023
$25K
UNRESTRICTED GENERAL SUPPORT
2022
$18K
IN FURTHERANCE OF GRANTEE'S TAX-EXEMPT PURPOSE
2022
$11K
FOR RECIPIENT'S EXEMPT PURPOSE
2022
$8K
FUNDING RESEARCH GRANTS IN CANCER RESEARCH
2022
$6K
PUBLIC CHARITY
2022
$1K
GENERAL SUPPORT
2022
$150
GENERAL
2022
$15K
GENERAL SUPPORT
2021
$4K
PUBLIC CHARITY
2021
$150
GENERAL
2021
$36K
TO ACHIEVE CHARITABLE PURPOSES
2020
$15K
General support
2020
$8K
FUNDING RESEARCH GRANTS IN CANCER RESEARCH
2020
$4K
PUBLIC CHARITY
2020
$150
GENERAL
2020
$50K
GENERAL PURPOSES
2019
$25K
UNRESTRICTED GENERAL SUPPORT
2019
$20K
General support
2019
$15K
CHARITABLE CONTRIBUTION TO PUBLIC CHARITY
2019
$180
GENERAL PURPOSE
2019
$150
GENERAL
2019
$20K
General Support
2018
$8K
PUBLIC CHARITY
2018
$17K
General Support
2017
$10K
CHARITABLE CONTRIBUTION TO PUBLIC CHARITY
2017
$1K
THE PURPOSE OF THESE CONTRIBUTIONS IS TO PROVIDE THE DONEE ORGANIZATIONS TO CARRY OUT THEIR EXEMPT FUNCTIONS.
2017

Funded by

$601K from 24 funders · 56 grants · 2017–2024

Jewish Communal Fund

$120K · 7 grants · 2017–2023

Morgan Stanley Global Impact Funding Trust Inc

$105K · 4 grants · 2019–2024

The Applebaum Foundation Inc

$100K · 2 grants · 2019–2020

Donor Advised Charitable Giving Inc

$48K · 6 grants · 2018–2023

Antoinette E Mimi & Herman Boehm

$36K · 1 grant · 2020

Vanguard Charitable Endowment Program

$28K · 2 grants · 2022–2023

The Sgmg Foundation

$26K · 5 grants · 2018–2023

The Donna And Marvin Schwartz

$25K · 2 grants · 2017–2019

Details

EIN136272085
Subsection03
Ruling date1968-06
Formed1968
Employees3
Volunteers40
CANCER RESEARCH & TREATMENT FUND INC — Mission, Financials & Grants Received | Grantivo